Figure 3.
Representative reconstructed and processed maximum intensity projections of female athymic (NCr) nu/nu mice bearing (A) human pancreatic carcinoma SHAW, (B) human colorectal carcinoma HT29, (C) human prostate carcinoma DU145 and (D) human ovarian carcinoma SKOV3 tumor xenografts injected i.v. with 3.8–4.0 MBq of 86Y-CHX-A”-DTPA-cetuximab. The tumors are indicated with a white arrow.
